Skip to main content
OpenTrials
Completed

NCT Number: NCT06788704

Tadalafil Daily Used Post Turp

to assess the effect of early tadalafil 5 mg once daily on persistent storage lower urinary tract symptoms (LUTS) and erectile function after transurethral resection of the prostate (TURP).

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Erectile Dysfunction Following Urethral Surgery

Sex eligibility

Male

Study type

Observational

Primary location

Elsayed Abdelhalim Elsayed

Zagazig, 44749, Egypt

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • sexual active men

Exclusion criteria

  • sexual inactive men
  • cardiac patients

Treatment and study plan

Tadalafil 5mg

Drug

Patient recive tadalafil 5mg once daily early post turp

Placebo

Drug

Patient recive placebo once daily early post turp

Primary outcomes

  1. Assess erectile function

    Time frame: One month

    Using IIEF score

  2. Assess erectile function

    Time frame: 3 month

    Usine IIEF score

Secondary outcomes

  1. Assess storage symptoms

    Time frame: One month

    Using IPSS Score

  2. Assess storage symptoms

    Time frame: 3 month

    Using IPSS score

Sponsors and collaborators

Lead sponsor

Kafrelsheikh University

Other

Registry information

Official study title

The Effect of Tadalafil 5 mg on Erection and Persistent Storage Lower Urinary Tract Symptoms After Transurethral Resection of Prostate: a Randmized Controlled Trial

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jan 23, 2025
Registry last updated
Jan 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.